| Present | Associate Professor, University of South Florida ‐ Internal Medicine | |
|
|
||
Disciplines
Research Interests
Research objective is to determine on how unresolved chronic inflammation and immune responsive metabolic dysregulation contributes to ischemic and non-ischemic heart failure and Halade lab research focuses on 1) study of heart failure etiology with an integrative approach focusing on splenic leukocytes and heart, 2) measurement of inflammatory mediators that impair cardiac repair and resolving lipid mediators that facilitate cardiac repair after heart attack, 3) role of resolution receptor in inflammation-resolution processes in heart failure, and 4) translate our findings for use in human therapy, considering risk factors such as obesity, diabetes, aging, and co-medications (oncological drugs)
Grants
| 2018 - 2023 | A Mir-486/Dock3 Signaling Axis Modulates Dystrophin-Deficient Pathology |
| NIH | |
| Role: Co-Investigator | |
| $1,112,865 | |
| 2019 - 2022 | Lipoxygenase Signaling in Heart Failure Pathology |
| NIH | |
| Role: PI | |
| $1,485,500 | |
| 2016 - 2021 | Resolution of Inflammation in Heart Failure Post-Myocardial Infarction |
| NIH | |
| Role: PI | |
| $1,837,500 | |
| 2018 - 2020 | Lipoxygenase Signaling in Heart Failure Pathology |
| School of Medicine AMC21 2018 1R01-2R01, The University of Alabama at Birmingham | |
| Role: PI | |
| $100,000 | |
| 2017 - 2019 | Cardiac dysfunction and remodeling after severe pneumonia - No overlap |
| The University of Alabama at Birmingham (CCVC/I3: Pilot grant) | |
| Role: Co-Investigator | |
| $50,000 |
Professional Service and Affiliations
| 2015 - Present | Associate Editor, Scientific Reports | 2013 - Present | Associate Editor, American Journal of Physiology – Heart and Circulatory | 2013 - Present | Editorial Board, Journal of Cardiology and Clinical Research | 2012 - Present | Member, American Physiology Society | 2010 - Present | Member, American Heart Association |
Honors and Awards
- 2020 - Article Impact Award for manuscript entitled ‘Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium (Altmetric score: 151)
- 2019 - Eicosanoid Research Foundation - Young Investigator Award Finalist, at the 16th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, St Petersburg, FL
- 2019 - Department of Medicine Innovation in Research Award, UAB
- 2012 - Sudhir Gupta Young Investigator Award from Association of Scientists of Indian Origin in America (ASIOA), Inc. San Diego, CA
| 2001 - 2007 | Ph.D., Institute of Chemical Technology | |
|
|
||
| 1998 - 2000 | M.S., Birla Institute of Technology | |
|
|
||
| 1994 - 1998 | B.S., North Maharashtra University | |
|
|
||
